CoChat

Inhibition of phosphodiesterase‐3 by levosimendan is sufficient to account for its inotropic effect in failing human heart

Open access
Ørstavik, Ø, Ata, S H, Riise, J, Dahl, C P, Andersen, G Ø, Levy, F O, Skomedal, T, Osnes, J‐B, Qvigstad, E · 2014 · British Journal of Pharmacology
Cited by 74

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Levosimendan is known as a calcium sensitizer, although it is also known to inhibit PDE 3. We aimed to isolate each component and estimate their contribution to the increased cardiac contractility induced by levosimendan. Experimental Approach: Contractile force was measured in electrically stimulated ventricular strips from explanted failing human hearts and left ventricular strips from normal male Wistar rats.PDE activity was measured in a two‐step PDE activity assay on failing human ventricle. Key Results: Levosimendan exerted a positive inotropic effect (PIE) reaching maximum at 10−5 M in ventricular strips from failing human hearts. In the presence of the selective PDE3 inhibitor cilostamide, the PIE of levosimendan was abolished. During treatment with a PDE4 inhibitor and a supra‐threshold concentration of isoprenaline, levosimendan generated an amplified inotropic response. This effect was reversed by β‐adrenoceptor blockade and undetectable in strips pretreated with cilostamide. Levosimendan (10−6 M) increased the potency of β‐adrenoceptor agonists by 0.5 log units in failing human myocardium, but not in the presence of cilostamide. Every inotropic response to levosimendan was associated with a lusitropic response. Levosimendan did not affect the concentration–response curve to calcium in rat ventricular strips, in contrast to the effects of a known calcium sensitizer,EMD 57033 [5‐(1‐(3,4‐dimethoxybenzoyl)‐1,2,3,4‐tetrahydroquinolin‐6‐yl)‐6‐methyl‐3,6‐dihydro‐2H‐1,3,4‐thiadiazin‐2‐one].PDE activity assays confirmed that levosimendan inhibited PDE3 as effectively as cilostamide. Conclusions and Implications: Our results indicate that the PDE3‐inhibitory property of levosimendan was enough to account for its inotropic effect, leaving a minor, if any, effect to a calcium‐sensitizing component.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12647

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Ørstavik, Ø., Ata, S. H., Riise, J., Dahl, C. P., Andersen, G. Ø., Levy, F. O., Skomedal, T., Osnes, J., & Qvigstad, E.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-11-24
Volume
171
Issue
23
Pages
5169-5181
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1822797420
Cited by
74
References
3
FWCI
1.83
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.